For research use only ยท Not for human or animal consumption
// Tissue & Cellular

KLOW Blend Research Guide

A four-component research blend of GHK-Cu, BPC-157, TB-500 and KPV (80 mg per vial). Summarizes the research on each component.

5Sources
3FAQs
4Min read
For research use only. Not for human consumption.
01

What is KLOW Blend?

KLOW is a four-component laboratory research blend. Per our product records, each vial contains GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, for 80 mg in total. See the product page for current specifications.

GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine (Maquart et al., 1988). BPC-157 is a synthetic 15-amino-acid peptide (Chang et al., 2011). TB-500 is the acetylated LKKTETQ fragment of thymosin beta-4 (Ho et al., 2012). KPV is the Lys-Pro-Val tripeptide from the C-terminal end of alpha-MSH (Dalmasso et al., 2008). Each component has its own guide.

02

Research areas studied

The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.

GHK-Cu research

In fibroblast cultures, GHK-Cu stimulated collagen synthesis at very low concentrations, independent of changes in cell number. A GHK sequence occurs in the alpha 2(I) chain of type I collagen (Maquart et al., 1988).

BPC-157 research

In rat tendon explants and cultured tendon fibroblasts, BPC-157 increased fibroblast outgrowth, survival under oxidative stress and migration, without directly changing proliferation (Chang et al., 2011). The evidence base is almost entirely preclinical.

TB-500 research

The LKKTETQ segment is described as the region of thymosin beta-4 responsible for actin binding and cell migration. Peer-reviewed work on the acetylated fragment itself is mainly analytical (Ho et al., 2012).

KPV research

In human intestinal epithelial and T-cell lines, KPV was taken up through the PepT1 transporter and inhibited NF-ฮบB and MAP kinase inflammatory signaling. In mice, KPV in drinking water reduced the incidence of chemically induced colitis (Dalmasso et al., 2008).

What has not been studied

We found no peer-reviewed studies of this combination. Blend-specific findings cannot be inferred from component research alone, and interactions between the four components have not been studied in the sources reviewed.

Regulatory status

None of the components is an approved drug. FDA’s compounding safety page lists BPC-157, the thymosin beta-4 fragment, GHK-Cu for injectable routes and KPV among nominated substances whose nominations were withdrawn, and reports no identified human exposure data for KPV or the thymosin beta-4 fragment.

03

Storage and handling

Like most research blends, KLOW Blend is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.

When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.

04

Quality and COA

Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.

05

KLOW Blend FAQ

What is in a KLOW 80mg vial?

Per our product records, GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, for 80 mg in total.

How is KLOW different from GLOW?

KLOW adds KPV 10 mg to the three GLOW components (GHK-Cu, BPC-157 and TB-500).

Has the KLOW combination been studied?

We found no peer-reviewed studies of this combination. The published research covers each component separately.

07

References

  1. Maquart FX, Pickart L, Laurent M, et al. (1988). FEBS Lett. PubMed 3169264
  2. Chang CH, Tsai WC, Lin MS, et al. (2011). J Appl Physiol. PubMed 21030672
  3. Ho EN, Kwok WH, Lau MY, et al. (2012). J Chromatogr A. PubMed 23084823
  4. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. (2008). Gastroenterology. PubMed 18061177
  5. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 28, 2026. fda.gov

For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.

Get 15% Off Your First Order

Join the Zero Zero Collection list for restock alerts, new COAs and member pricing. Research use only.